FSA Wealth Management’s Praxis Precision Medicines PRAX Stock Holding History

FSA Wealth Management’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$1.11K	Hold	21	–	–	﹤0.01%	527
2025 Q2	$883	Hold	21	–	–	﹤0.01%	510
2025 Q1	$795	Hold	21	–	–	﹤0.01%	479
2024 Q4	$1.62K	Hold	21	–	–	﹤0.01%	499
2024 Q3	$1.21K	Buy	+21	New	+$1.13K	﹤0.01%	517
2024 Q1	$1.28K	Hold	21	–	–	﹤0.01%	567
2023 Q4	$0	Buy	+21	New	+$378	﹤0.01%	590

Other funds holding PRAX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

FSA Wealth Management's PRAX Position: Q3 2025 in Review

FSA Wealth Management held its Praxis Precision Medicines (PRAX) position steady in Q3 2025 at 21 shares worth $1.11K. The position accounts for ﹤0.01% of the portfolio, ranked #527.

FSA Wealth Management first reported a position in PRAX in Q4 2023 and has held it in 7 quarters since. The position peaked at $1.62K in Q4 2024. 152 funds tracked by Wall St. Rank hold PRAX as of Q3 2025.

FSA Wealth Management held 21 shares of Praxis Precision Medicines worth $1.11K as of Q3 2025.
FSA Wealth Management left its Praxis Precision Medicines share count unchanged in Q3 2025.
Praxis Precision Medicines made up ﹤0.01% of FSA Wealth Management's portfolio in Q3 2025, its #527 holding.
FSA Wealth Management first reported a position in Praxis Precision Medicines in Q4 2023 and has held it in 7 quarters since.
FSA Wealth Management's Praxis Precision Medicines position peaked at $1.62K in Q4 2024.
152 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2025.

Based on FSA Wealth Management's 13F filing for Q3 2025, filed 17 Nov 2025.